MAM
IPSC icon

Martingale Asset Management’s Century Therapeutics IPSC Stock Holding History

Martingale Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,151
Closed -$155K – 815
2023
Q2 		$155K Hold
49,151
– – ﹤0.01% 777
2023
Q1 		$171K Buy
+49,151
New +$216K ﹤0.01% 790

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Martingale Asset Management's IPSC Position: Q3 2023 in Review

Martingale Asset Management sold out of Century Therapeutics (IPSC) in Q3 2023, closing a stake of 49,151 shares — an estimated $155K sold.

Martingale Asset Management first reported a position in IPSC in Q1 2023 and held it in 2 quarters. The position peaked at $171K in Q1 2023. 55 funds tracked by Wall St. Rank hold IPSC as of Q3 2023.

  • Martingale Asset Management reported no remaining Century Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Martingale Asset Management sold 49,151 Century Therapeutics shares in Q3 2023, an estimated $155K.
  • Martingale Asset Management first reported a position in Century Therapeutics in Q1 2023 and held it in 2 quarters.
  • Martingale Asset Management's Century Therapeutics position peaked at $171K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2023.

Based on Martingale Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.